Foresite Capital Management II as of Sept. 30, 2019
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 7 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| 10x Genomics Inc Cl A (TXG) | 72.8 | $345M | 6.8M | 50.40 | |
| Aimmune Therapeutics | 11.5 | $55M | 2.6M | 20.94 | |
| Aerie Pharmaceuticals | 6.8 | $32M | 1.7M | 19.22 | |
| Insmed (INSM) | 3.4 | $16M | 915k | 17.64 | |
| Epizyme | 3.2 | $15M | 1.5M | 10.31 | |
| Acceleron Pharma | 1.6 | $7.5M | 189k | 39.51 | |
| Alder Biopharmaceuticals | 0.6 | $2.8M | 147k | 18.86 |
